The essentials
Desogestrel contraceptives linked to 1.7-fold meningioma risk; European and French authorities issue alert.
French health authorities have alerted approximately 1.6 million women using desogestrel contraceptives about an increased risk of meningioma, a type of brain tumor. The French health agency (ANSM) has sent alert letters to 90,000 healthcare professionals, and the European Medicines Agency has updated product information to include this safety finding.
Research indicates that desogestrel use increases meningioma risk by 1.7-fold after five years of use. The risk is particularly pronounced in women over 45 and those with prior progestin use. Women experiencing potential meningioma symptoms are advised to consult their doctors.
Authorities emphasize that desogestrel's meningioma risk remains significantly lower than other progestins, and women should not stop taking their contraception without medical guidance. The alert aims to inform both healthcare providers and patients to enable informed decision-making about continued use.
Other ways to read this story.
Alternative framings generated by SigNews. These are not independent sources or attributed quotations.
Authorities act to inform patients and providers of emerging safety signal
The French health agency and European Medicines Agency have coordinated a systematic alert, sending notifications to 90,000 healthcare professionals and updating product labeling. This proactive approach prioritizes information distribution while cautioning users against abrupt discontinuation without medical consultation, balancing safety awareness with clinical continuity.
Meningioma association identified within broader contraceptive safety profile
While desogestrel use shows a 1.7-fold increase in meningioma risk after five years, particularly for women over 45, this risk remains lower than alternatives. The alert enables targeted risk assessment for high-risk groups, allowing healthcare providers and patients to weigh benefits and risks based on individual circumstances rather than blanket recommendations.